FOR IMMEDIATE RELEASE
David W. Moskowitz MD
Donald Njikam PharmD
CEO, Kaya Holdings
Tel. 813.546.2209 (U.S.)
ST. LOUIS—June 23, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it has partnered with Pharmacie Principale, a retail pharmacy in Yaounde, the capital city of Cameroon, in Central Africa.
Pharmacie Principale will educate its customers with type 2 diabetes, high blood pressure, and emphysema about GenoMed’s Clinical Outcomes Improvement Program (COIP®).
In addition, Pharmacie Principale will tell patients about GenoMed’s Phase IV trials for serious diseases such as metastatic cancer, sickle cell disease, HIV, ebola, dengue, etc.
David W. Moskowitz, MD FACP, GenoMed’s CEO and Chief Medical Officer, said “Education is key. We’re delighted that Pharmacie Principale is as eager as we are to serve their clients’ health needs. We look forward to a long and fruitful association with Pharmacie Principale and their clients.”
Said Donald Njikam, PharmD, CEO of Kaya Holdings, which owns Pharmacie Principale, “We’re excited to use our pharmacy to educate our customers about state-of-the-art healthcare techniques. Retail pharmacies are a tremendous resource. So far, GenoMed is the only company I know of that recognizes their full potential.”
Added Dr. Njikam, “I’m surprised that Dr. Moskowitz’s published results have received such little attention in the US. His techniques are simple enough for any pharmacy to implement. We are collaborating closely by email on each patient in a form of tele-medicine and by so doing making expert health care consultations easily accessible to patients in the developing world at a fraction of the cost.”
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. As the only Public Health Company™ in the world, GenoMed aims to arrest diabetes, hypertension, and emphysema everywhere on earth. Please contact Dr. Moskowitz if you have one of these diseases.
About Kaya Holdings/Pharmacie Principale
Pharmacie Principale is an independent retail pharmacy in the capital city of Yaounde, Cameroon, Central Africa. National law prevents anyone from owning more than a single pharmacy, so there are no pharmacy chains in Cameroon. Pharmacie Principale wants to make available the best healthcare possible to its customers by providing the same cutting edge therapy available to US patients delivered by U.S based specialists through telemedicine.
Safe Harbor Statement
This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.’s (the Company’s) finances and treatments. The words or phrases “ought to,” “should,” “could,” “may,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.